Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16485000 | 0.94 | KDM4E (0.40) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL26413396 | 0.92 | KDM4E (0.34) | KDM4EATML3MBTL1 | |
| SCHEMBL18086297 | 0.91 | KDM4E (0.42) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL18086293 | 0.91 | KDM4E (0.42) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL18121199 | 0.91 | KDM4E (0.42) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL24990659 | 0.90 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL19726500 | 0.90 | KDM4E (0.37) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL25098793 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL12104914 | 0.88 | KDM4E (0.38) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL18086265 | 0.87 | KDM4E (0.41) | KDM4EATML3MBTL1MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960364-B2 | Ladder compound, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMIITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | US | disclosed |
| WO-2014057684-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 出光興産株式会社 (JP) | 2014-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270496-A1 | LADDER COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | YBX1, ATXN2L, ATXN2 | KDM4E 2405/4885ATM 3393/4885L3MBTL1 106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.